3Indexed trials
drug · Product Intelligence
SEP-363856
Pipeline Intelligence
SEP-363856: 3 indexed trials, 2 sponsors; 0 linked Orange Book patents and 0 FDA-linked events where matched.
2Sponsors
0Orange Book patent links
0FDA-linked events
Development evidence
NCT01994473Otsuka Pharmaceutical Development & Commercialization, Inc. · schizophreniaPHASE1
NCT05359081Sumitomo Pharma Co., Ltd. · schizophreniaPHASE3
NCT05402111Otsuka Pharmaceutical Development & Commercialization, Inc. · schizophreniaPHASE1
FDA / patent evidence
No FDA Orange Book product match is asserted for this intervention.
Regulatory context
FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.